<DOC>
	<DOCNO>NCT01830764</DOCNO>
	<brief_summary>The purpose study assess safety tolerability lemuteporfin topical solution ( LTS ) exposure red light ( PDT ) , applied back healthy volunteer .</brief_summary>
	<brief_title>Open-label Safety Tolerability Study LTS-PDT Healthy Volunteers</brief_title>
	<detailed_description>This open-label , safety study healthy volunteer . Two cohort , 6 subject , enrol ( total subject = 12 ) . Each subject test area identify back receive single LTS , vehicle solution red light ( PDT ) apply test area back . Subjects follow safety study visit occur Day 1 ( baseline treatment ) , Day 2 , Day 7 .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>1 . Healthy adult 18 year age old 2 . Fitzpatrick skin type IIV 1 . Current pregnancy lactation . 2 . Presence severe facial acne , acne fulminans conglobata , nodulocystic acne . 3 . Poor skin condition back , include erythema , dryness , sunburn , dermatological malignancy , infection , cut , abrasion , tattoo , excess hair skin condition 4 . Subjects used agent know produce significant photosensitivity reaction ( tetracycline , phenothiazine , trimethoprim , etc . ) within 2 week Day 1 5 halflives , whichever longer . 5 . Subjects use medicated topical therapy back within 3 day Day 1 . 6 . Chronic treatment low dose aspirin , nonsteroidal anti inflammatory drug ( NSAID ) , anticoagulant regimen warfarin ( Coumadin ) . 7 . Abnormal finding screen ECG deem clinically significant Investigator . 8 . Active participation experimental therapy study experimental therapy within 30 day Day 1 . 9 . Screening clinical chemistry hematology laboratory value consider clinically significant , opinion Investigator . 10 . Subjects poor medical risk systemic disease active uncontrolled infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>